Management of Anemia in COVID-19 Patients

Introduction to Anemia Management

• The American College of Physicians recommends managing anemia in COVID-19 patients with erythropoiesis-stimulating agents and iron supplementation to minimize transfusion burden, while carefully monitoring for potential complications related to both the underlying COVID-19 infection and the treatment 1

Transfusion and Growth Factor Support

• Consider using erythropoiesis-stimulating agents or erythropoiesis maturation agents to minimize transfusion burden in COVID-19 patients, and follow transfusion contingency plans as recommended by guidelines 1
• Maintain absolute neutrophil count >1000 cells/μL across all phases of therapy, and consider liberal use of growth factor support in patients without active COVID-19 to facilitate neutrophil count recovery 1
• Reconsider growth factor use in moderate-to-severe COVID-19 due to potential risk of worsening pulmonary complications 1
• The following table outlines the management approach for neutropenia based on severity:

Diagnosis and Evaluation

• Evaluate serum ferritin, serum iron, total iron binding capacity, and transferrin saturation to diagnose iron deficiency, noting that serum ferritin may be falsely elevated in inflammatory conditions like long COVID 2
• Perform a complete blood count with reticulocyte count, vitamin B12 and folate levels, and peripheral blood smear to assess for microcytosis, hypochromia, or other abnormalities in patients with mild anemia and long COVID 2
• Consider upper and lower GI endoscopy to rule out occult GI blood loss, especially if iron deficiency is confirmed, in patients with long COVID and thyroid autoimmunity 2

Treatment and Management

• The American Gastroenterological Association recommends iron supplementation as the first-line treatment for iron deficiency anemia, with oral iron supplementation (ferrous sulfate 325 mg daily or equivalent) and monitoring of response with repeat CBC in 4-6 weeks 2
• Consider vitamin B12 supplementation if levels are low, and folate supplementation if indicated, in patients with mild anemia and long COVID 2
• The American College of Physicians recommends considering erythropoiesis-stimulating agents to reduce transfusion burden in patients with persistent anemia, as supported by The Lancet Haematology 1
• Regular CBC monitoring should be performed every 4-6 weeks, with more frequent monitoring (every 2-4 weeks) if anemia worsens or if neutropenia is present 1, 2
• Hematology consultation is recommended if anemia worsens despite iron supplementation, additional cytopenias develop, or anemia persists beyond 4-6 weeks of appropriate therapy, or if neutropenia worsens, ANC drops below 1000/mcL, or neutropenia persists beyond 4-6 weeks 1, 3, 4, 5

Monitoring and Supportive Care

• Patients with long COVID and thyroid autoimmunity should be monitored for development of additional autoimmune disorders, such as autoimmune hemolytic anemia and immune thrombocytopenia 2
• Gastrointestinal complications should be monitored, and endoscopic evaluation should be considered if symptoms develop or anemia worsens 2
• Regular thyroid function monitoring, including TSH and free T4 every 3-6 months, is essential to monitor for symptoms of hypo- or hyperthyroidism, as COVID-19 may trigger changes in thyroid function 1
• Supportive care for other long COVID symptoms includes pacing and energy conservation techniques for fatigue, regular sleep schedule, and adequate hydration and balanced nutrition, as recommended by the American Academy of Sleep Medicine 6
• Avoid excessive physical activity, and implement careful pacing strategies, as physical activity worsened symptoms in 75% of long COVID patients, according to Nature Reviews Microbiology 7

Infection Prevention and Cardiac Evaluation

• Patients with neutropenia are at increased risk for bacterial and fungal infections, and empirical antibacterial therapy should be initiated promptly if fever develops 1
• Prophylactic antibiotics should be considered for patients with other risk factors 1
• The American College of Cardiology recommends cardiac evaluation to rule out myocardial injury, ECG monitoring, and considering echocardiogram if symptoms of cardiac dysfunction are present for patients with elevated CK-MB 8
• The National Lipid Association recommends dietary modifications and considering statin therapy if levels remain elevated after 3 months for patients with hypercholesterolemia 8
• The Centers for Disease Control and Prevention recommends regular follow-up and screening for rehabilitation needs during follow-up, as post-COVID neutropenia can persist or worsen, and patients with neutropenia are at increased risk for bacterial and fungal infections 6, 9